HISTORY OF PRESENT ILLNESS:  The patient is an 85-year-old female with a past medical history significant for paroxysmal atrial fibrillation, asthma, seizure disorder, no prior history of coronary artery disease (despite a positive troponin I during the hospitalization two years ago), who was admitted to the CCU following an episode of hypotension, bradycardia, and hypercarbic respiratory distress requiring intravenous inotropic support and intubation.
CCU COURSE:  The patient was intubated, pressors were utilized, and a temporary pacing wire was placed.
The patient developed a fever, and Levaquin was started on [**8-26**].
Vancomycin and Flagyl were initiated on [**8-28**] for persistent febrile episodes.
Catheter tip was cultured from [**9-2**], [**9-3**], [**9-5**], and [**9-16**] which were all negative for growth.
The patient was started on Ceftriaxone to cover Lyme disease, and Levaquin and Flagyl were discontinued on [**9-3**].
The patient was weaned off Levophed on [**9-4**], but Dopamine was continued.
Digoxin was initiated on [**9-4**], and pressors were finally weaned off completely on [**9-6**].
Breast cancer status post right mastectomy in [**2107**], status post radiation.
Recurrent osteomyelitis status post sternotomy in [**2140**].
Status post left hip arthroplasty.
p.r.n., Heparin drip, Ativan p.r.n., Reglan p.r.n., Ceftriaxone IV q.24 hours, Vancomycin 750 mg IV q.18 hours, Combivent 1-2 puffs, Depakote 750 mg p.o.
b.i.d., Digoxin 0.125 mg p.o.
q.o.d., Aspirin 325 mg p.o.
q.d., Protonix 40 mg p.o.
q.d., Morphine Sulfate q.4 hours p.r.n., Peri-Colace p.r.n., Magnesium Oxide 800 mg p.o.
LABORATORY DATA ON DISCHARGE:  WBC 6.3, hematocrit 34.0, platelet count 285; sodium 143, potassium 4.1, chloride 92, bicarb 39, BUN 42, creatinine 1.2, glucose 81, magnesium 1.9; PTT, PT, and INR were pending on the day of discharge, INR on the day prior to discharge was 3.4.
Video swallow on [**2145-9-14**], demonstrated aspiration with thin liquids which was effectively countered by bolus and chin tuck.
The patient had a permanent pacemaker placed on [**2145-9-13**], without complications.
Ischemia:  The patient experienced several episodes of substernal chest pressure associated with shortness of breath and nausea while admitted.
This was evaluated at rest, and the patient will continue to need supplemental oxygen and further evaluation for her requirement upon optimal diuresis.
Upon discharge, the patient was only on diuretics, and her medical regimen with be further optimized by her primary cardiologist as an outpatient.
She was started on broad-spectrum antibiotics and was followed by the Infectious Disease Service.
Upon transfer to the Medical Floor, the patient remained afebrile, hemodynamically stable, and received her last dose of antibiotics on [**2145-9-10**].
The patient received several units of packed red blood cells to keep her hematocrit above 30.
Prior to discharge, she was started on Heparin with a goal PTT of 50-70.
She was then initiated on Coumadin therapy with a goal INR of [**1-10**].
FEN:  The patient had a video swallow while admitted to evaluate for aspiration risk.
The patient tolerated food and liquids well prior to discharge.
Bradycardia status post pacemaker insertion.
DISCHARGE MEDICATIONS:  Protonix 40 mg p.o.
q.24 hours, Enteric Coated Aspirin 325 mg p.o.
Sodium 750 mg p.o.
b.i.d., Lasix 80 mg p.o.
b.i.d., Warfarin 2.5 mg p.o.
q.h.s., this will need to be titrated with constant monitoring of the PT/INR for the next two weeks (check INR three times a week), Ipratropium Bromide nebulizer 1 neb q.6 hours p.r.n., Albuterol nebulizer 1 neb treatment q.6 hours p.r.n., Peri-Colace 1 cap p.o.
p.r.n., Percocet [**12-9**] tab p.o.
q.4-6 hours p.r.n., Tylenol 325-650 mg p.o.
q.4-6 hours p.r.n., Bisacodyl 10 mg p.r.
p.r.n., Reglan 10 mg p.o.
p.r.n., Ativan 0.25-1.0 mg p.o./IV q.4-6 hours p.r.n.
The patient will require a PT/INR, electrolytes, and hematocrit checks three times per week during the next two weeks; to be checked while the patient is at the [**Hospital **] Rehabilitation Facility.
